Announcement on the Expiration of Share Reduction Period and Results for Shareholders Holding Over 5% of Shares
The shareholders Suzhou Saifu Puxin Medical Health Industry Investment Center (Limited Partnership), Huangshan Saifu Tourism Culture Industry Development Fund (Limited Partnership), Tianjin Saifu Shengyuan Investment Management Center (Limited Partnership) - Jiaxing Tengyuan Investment Partnership (Limited Partnership), and Beijing Daotong Changqing Investment Management Center (Limited Partnership) guarantee that the information provided to the company is true, accurate, and complete, without false records, misleading statements, or significant omissions. The company and all members of the board of directors ensure that the announcement content is consistent with the information provided by the information disclosure obligor.
Anhui Huaren Health Pharmaceutical Co., Ltd. disclosed the "Pre-disclosure Announcement on Share Reduction by Shareholders Holding Over 5% of Shares" (Announcement No.: 2026-001) on January 14, 2026, on the Giant Tide Information Network (www.cninfo.com.cn). Shareholders Suzhou Saifu, Huangshan Saifu, Tengyuan Investment, and Changqing Investment planned to reduce their holdings by no more than 8,000,000 shares (accounting for 2% of the company's total share capital) within three months after 15 trading days from the date of the announcement, through centralized bidding and block trading.
On April 30, 2026, the company received a notice from shareholders Suzhou Saifu, Huangshan Saifu, Tengyuan Investment, and Changqing Investment regarding the expiration of the share reduction plan. It was confirmed that during the implementation period of the reduction plan, a total of 4 million shares were sold through centralized bidding, accounting for 1% of the company's total share capital.